YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Pharmaceutical Whistleblower
Pharmaceutical Whistleblower
In recent years many pharmaceutical employees have come forward to report fraudulent billing, illegal marketing techniques and undisclosed drug side effects. These courageous people known as whistle blowers have helped the federal government recover millions of dollars that were obtained illegally by the pharmaceutical companies. More importantly whistle blowers have helped save the lives of thousands of prescription drug users that were previously unaware of their medication's side effects.Recently, a former Pfizer Microbiologist David Franklin blew the whistle on Pfizer's Warner-Lambert unit over promoting the epilepsy drug Neurontin for off-label uses. Franklin’s testimony led to the Government's recovery of over $400 million dollars from Pfizer. Franklin's reward will be about $26 million.
Franklin sued the company in 1996 under the False Claims Act. The False Claims Act is a US law that encourages employees to report illegal activities at their companies. The law was passed in 1863 to crack down on war-profiteering during the Civil War. It allows individuals to bring lawsuits on behalf of the federal Government and receive part of any settlement or judgment.
Last year, the Justice Department recovered $2.1 billion under the False Claims Act, up from $1.1 billion the previous year. Franklin's award is far from the largest. In 2001 Douglas Durand, a former vice-president of sales at TAP Pharmaceuticals, received $77 million for blowing the whistle on his employer.
If you are a current or former pharmaceutical company employee and have information on any illegal activities, please fill out the form at the right for a free case evaluation by a qualified attorney.
Pharmaceutical WhistleblowerRSS Feed
Ketek case keeps glare on reform
Feb 14, 2007 | The Star Ledger
The Food and Drug Administration's missteps in approving the controversial antibiotic Ketek were cited at a congressional hearing yesterday as further evidence of the need for major drug safety reform. FDA whistle-blowers, medical experts and members of Congress said the FDA in 2004 approved Ketek, since linked to liver failures, despite serious safety warnings from scientific reviewers and evidence of fraudulent data. They told the House Energy and Commerce subcommittee on oversight and...
Ex-J&J officer files lawsuit as whistle-blower
Dec 15, 2006 | Star Ledger
The former chief medical officer for a unit of Johnson & Johnson has filed a whistle-blower lawsuit against the company, claiming he was fired for seeking product recalls of several faulty medical devices. Joel Lippman said he was terminated from his post at Ethicon in May, after working at the subsidiary for almost six years. Before that, Lippman, 52, of Warren, helped oversee clinical trials for a decade at another J&J unit, Ortho-McNeil Pharmaceuticals. Lippman claims he...
Chief Medical Officer Blows Whistle On Johnson & Johnson
Dec 13, 2006 | www.courthousenews.com
Johnson & Johnson subsidiary Ethicon fired its chief medical officer because of his insistence that unsafe medical products be recalled, Dr. Joel Lippman claims in Middlesex County Court. Lippman claims that during 15 years in high-ranking medical positions at Ethicon and Ortho McNeil, another J&J subsidiary, Johnson & Johnson repeatedly released or refused to recall dangerous products to which he objected, including the Ortho-Evra birth control patch and Intergel. Both products...
Lawmaker Alleges FDA, Merck Collaborated
Jul 19, 2006 | AP
A federal health official worked with drug maker Merck to discredit a government whistleblower who publicized safety risks associated with the painkiller Vioxx, a lawmaker alleged Wednesday in seeking an investigation. Sen. Charles Grassley, R-Iowa, asked the inspector general at the Health and Human Services Department to probe whether the Food and Drug Administration and Merck acted in concert to call into question the safety findings made by Dr. David Graham, an FDA drug safety official. ...
Judge orders FDA whistleblower to testify
Mar 15, 2006 | AP
The Food and Drug Administration whistleblower who has criticized the agency's handling of Vioxx will be deposed, a judge ruled, offering evidence that could aid thousands of lawsuits over the withdrawn pain killer. A federal judge refused to grant a government motion to quash plaintiffs' lawyers subpoena of drug reviewer Dr. David Graham, who testified at a 2004 Congressional hearing that the Merck & Co. drug caused as many as 160,000 heart attacks and strokes. Graham questioned the...
Pharmaceutical Whistleblower
Quick Facts
Pharmaceutical Whistleblower Reference Guide
Types of Fraud
Fraudulent billing
Illegal marketing techniques
Side effect not disclosed
Types of Whistleblowers
Pharmacists
Microbiologists
Sales reps
Nurses
Physicians
Scientists
Researchers
Material handlers
Chemists
Interns
Related Topics
Medical Malpractice
Pharmacist Malpractice
Qui Tam
Malpractice
Other Topics
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS
